Psyence Group

Home » Archives for Psyence Group

About Psyence Group

This author has not yet filled in any details.
So far Psyence Group has created 58 blog entries.

GOODMIND Available For Sale In The United Kingdom And Europe – Exclusive Distribution Agreement Concluded With This Works.

2022-11-29T19:40:20+02:00November 29, 2022|Investor Information, Psychedelic News, Press Releases|

Psyence is pleased to announce that it has, together with its joint venture partner The Goodleaf Company (Pty) Ltd (“Goodleaf”), entered into an exclusive distribution agreement with This Works Products Limited (“This Works”) for the distribution and sale of the joint venture’s functional mushroom brand, GOODMINDTM, in the United Kingdom and Europe.

  • Psyence Clinical Trials

Psyence Group Receives Phase IIa Clinical Trial Approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA)

2022-09-19T13:05:24+02:00September 19, 2022|Press Releases, Investor Information|

Psyence has partnered with a leading psychedelic Contract Research Organisation (CRO), Clerkenwell Health, to design and deliver the clinical trial. Clerkenwell has experience in conducting psychedelic research and the trial will be conducted at two centers in the United Kingdom.

Go to Top